|
|
Via di Castel Romano 100
Roma, 00128 Italy
phone:(39) 06 80 31 90 53
fax:(39) 06 80 31 90 65
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.laylinegenomics.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| New drugs and innovative therapies for Alzheimer's and other neurological diseases. |
|
| Management |
| Antonino Cattaneo, President and CSO; Ennio Esposito, CEO; Fernando Carlo Giuliani, Strategic Business & Product Development Manager; Roberta Gioia, CFO; Simona Capsoni, Responsible for Alzheimer's disease Program; Michela Visintin, Responsible for SPLNT technology; Gabriele Ugolini, Responsible for Neuroantibodies / Chronic Pain; Elisabetta Balestrieri, Business Development |
| |
|
|
| |
|
| Keywords |
| functional, proteomics, drug, drugs, alzheimer's, neurological, diseases, technology, protein, knock-out, intracellular, targeting, recombinant, antibodies |
|
|
|
| Description |
|
Lay Line Genomics is focused ong functional proteomics. The company's mission is to develop new drugs and innovative therapies for Alzheimer's and other neurological diseases, exploiting its unique technology platform for protein knock-out. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members